Bessemer Group Inc Exact Sciences Corp Transaction History

Bessemer Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $329 - $495	5 New	5 $0
Q1 2022 May 12, 2022	SELL	$57.56 - $82.54 $16,174 - $23,193	-281 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$99.61 - $142.12 $27,990 - $39,935	281 New	281 $37,000
Q1 2020 Apr 30, 2020	SELL	$37.9 - $104.44 $1,516 - $4,177	-40 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$89.51 - $118.04 $95,149 - $125,476	-1,063 Reduced 96.37%	40 $5,000
Q4 2018 Feb 12, 2019	BUY	$56.04 - $82.66 $5,772 - $8,513	103 Added 10.3%	1,103 $69,000
Q2 2018 Jul 25, 2018	SELL	$37.84 - $69.96 $37,840 - $69,960	-1,000 Reduced 50.0%	1,000 $60,000
Q3 2017 Nov 03, 2017	BUY	$37.05 - $47.12 $74,100 - $94,240	2,000	2,000 $94,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.59B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.